Dan Corbett

Dan Corbett is an experienced professional in pharmaceutical sales with a focus on neuroscience and behavioral health. Currently serving as a Neuroscience Sales Specialist Overlay at Intra-Cellular Therapies since March 2020, Dan has successfully launched CAPLYTA for the treatment of schizophrenia and bipolar depression in Pennsylvania. Prior roles include Senior Clinical Specialist at Indivior, where Dan launched PERSERIS for schizophrenia, and Neuroscience Specialty Representative at Vanda Pharmaceuticals, promoting solutions for sleep disorders and schizophrenia. Dan's extensive background encompasses positions at IQVIA, BSN Medical, AstraZeneca, and other companies, highlighting a proven track record in achieving sales targets and fostering relationships with healthcare professionals. Dan holds a Bachelor of Science in Communications Media from Indiana University of Pennsylvania.